GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Short-Term Capital Lease Obligation

Alto Neuroscience (Alto Neuroscience) Short-Term Capital Lease Obligation : $0.05 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Short-Term Capital Lease Obligation?

Alto Neuroscience's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.05 Mil.

Alto Neuroscience's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 ($0.20 Mil) to Dec. 2023 ($0.13 Mil) and declined from Dec. 2023 ($0.13 Mil) to Mar. 2024 ($0.05 Mil).

Alto Neuroscience's annual Short-Term Capital Lease Obligation increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.28 Mil) but then declined from Dec. 2022 ($0.28 Mil) to Dec. 2023 ($0.13 Mil).

Alto Neuroscience Short-Term Capital Lease Obligation Historical Data

The historical data trend for Alto Neuroscience's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Short-Term Capital Lease Obligation Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
- 0.28 0.13

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial 0.28 - 0.20 0.13 0.05

Alto Neuroscience Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Alto Neuroscience Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024